1). Kauffmann RH., Herrmann WA., Meyer CJ., Daha MR., Van Es LA. Circulating IgA-immune complexes in Henoch-Schonlein purpura. A longitudinal study of their relationship to disease activity and vascular deposition of IgA. Am J Med. 1980. 69:859–66.
2). O'Donoghue DJ., Darvill A., Ballardie FW. Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-SchoUnlein purpura. J Clin Invest. 1991. 88:1522–30.
3). Saulsbury FT. Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore). 1999. 78:395–409.
4). Blanco R., Martinez-Taboada VM., Rodriguez-Valverde V., Garcia-Fuentes M., Gonzalez-Gay MA. Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum. 1997. 40:859–64.
5). de Almeida JL., Campos LM., Paim LB., Leone C., Koch VH., Silva CA. Renal involvement in Henoch-Schonlein purpura: a multivariate analysis of initial prognostic factors. J Pediatr (Rio J). 2007. 83:259–66.
6). Kaku Y., Nohara K., Honda S. Renal involvement in Henoch-SchoUnlein purpura: a multivariate analysis of prognostic factors. Kidney Int. 1998. 53:1755–9.
7). Sano H., Izumida M., Shimizu H., Ogawa Y. Risk factors of renal involvement and significant proteinuria in Henoch-SchoUnlein purpura. Eur J Pediatr. 2002. 161:196–201.
8). Shin JI., Park JM., Shin YH., Hwang DH., Kim JH., Lee JS. Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-SchoUnlein purpura. Scand J Rheumatol. 2006. 35:56–60.
9). Kellerman PS. Henoch-SchoUnlein purpura in adults. Am J Kidney Dis. 2006. 48:1009–16.
10). Garcia-Porrua C., Gonzalez-Louzao C., Llorca J., Gonzalez-Gay MA. Predictive factors for renal sequelae in adults with Henoch-SchoUnlein purpura. J Rheumatol. 2001. 28:1019–24.
11). Garcia-Porrua C., Calvino MC., Llorca J., Couselo JM., Gonzalez-Gay MA. Henoch-SchoUnlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum. 2002. 32:149–56.
12). Uppal SS., Hussain MA., Al-Raqum HA., Nampoory MR., Al-Saeid K., Al-Assousi A, et al. Henoch-SchoUnlein's purpura in adults versus children/adolescents: a comparative study. Clin Exp Rheumatol. 2006. ;24 Suppl: 26-30S.
13). Hong JH., Na HJ., Namgoong MK., Choi SO., Han BG., Jung SH, et al. Different Clinical Courses of Henoch-SchoUnlein Purpura in Children, Adolescents and Adults. Korean J Pediatr. 2005. 48:1244–51.
14). Kwon EH., Kim SJ., Na MA., Jung YS., Lee DW., Lee SB, et al. A clinicopathological study of the adult Henoch-SchoUnlein Purpura. Korean J Med. 2003. 65:323–34.
15). Kim KE., Shin YH., Shin JI., Park JM., Lee JS., Jeong HJ. Clinical Comparison of Henoch-SchoUnlein Purpura Nephritis in Children and Adults. J Korean Soc Pediatr Nephrol. 2003. 7:157–65.
16). Kim NH., Ham YR., Yoon JH., Jung JY., Kim ES., Chung S, et al. Henoch-SchoUnlein Nephritis in Adults: Renal Outcomes and Prognostic Factors. Korean J Nephrol. 2009. 28:570–8.
17). Ozen S., Pistorio A., Iusan SM., Bakkaloglu A., Herlin T., Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch-SchoUnlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010. 69:798–806.
18). Mills JA., Michel BA., Bloch DA., Calabrese LH., Hunder GG., Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-SchoUnlein purpura. Arthritis Rheum. 1990. 33:1114–21.
19). Counahan R., Winterborn MH., White RH., Heaton JM., Meadow SR., Bluett NH, et al. Prognosis of Henoch-Schonlein nephritis in children. Br Med J. 1977. 2:11–4.
Article
20). Watts RA., Jolliffe VA., Grattan CE., Elliott J., Lockwood M., Scott DG. Cutaneous vasculitis in a defined population—clinical and epidemiological associations. J Rheumatol. 1998. 25:920–4.
21). Uthman I., Kassak K., Nasr FW. Henoch-SchoUnlein purpura in adulthood and childhood: comment on the article by Blanco et al. Arthritis Rheum. 1998. 41:1518–20.
22). Coppo R., Andrulli S., Amore A., Gianoglio B., Conti G., Peruzzi L, et al. Predictors of outcome in Henoch-SchoUnlein nephritis in children and adults. Am J Kidney Dis. 2006. 47:993–1003.
23). Ilan Y., Naparstek Y. SchoUnlein-Henoch syndrome in adults and children. Semin Arthritis Rheum. 1991. 21:103–9.
24). Ilan Y., Naparstek Y. Henoch SchoUnlein purpura in children and adults: is it one entity? Semin Arthritis Rheum. 2002. 32:139–40.
25). Ergin S., Sanli Erdogan B., Turgut H., Evliyaoglu D., Yalcin AN. Relapsing Henoch-SchoUnlein purpura in an adult patient associated with hepatitis B virus infection. J Dermatol. 2005. 32:839–42.
26). Veraldi S., Mancuso R., Rizzitelli G., Gianotti R., Ferrante P. Henoch-SchoUnlein syndrome associated with human Parvovirus B19 primary infection. Eur J Dermatol. 1999. 9:232–3.
27). Saurina A., Botey A., Sole M., Vera M., Pou M., Torras A, et al. Henoch-SchoUnlein purpura nephritis associated with coagulase-negative staphylococci sepsis in a patient with myeloma. Nephrol Dial Transplant. 2001. 16:2441–2.
28). Galaria NA., Lopressti NP., Magro CM. Henoch-SchoUnlein purpura secondary to subacute bacterial endocarditis. Cutis. 2002. 69:269–73.
29). Pertuiset E., Liote F., Launay-Russ E., Kemiche F., Cerf-Payrastre I., Chesneau AM. Adult Henoch-SchoUnlein purpura associated with malignancy. Semin Arthritis Rheum. 2000. 29:360–7.
30). Weiler-Bisig D., Ettlin G., Brink T., Arnold W., Glatz-Krieger K., Fischer A. Henoch-schoUnlein purpura associated with esophagus carcinoma and adenocarcinoma of the lung. Clin Nephrol. 2005. 63:302–4.
31). Day C., Savage CO., Jones EL., Cockwell P. Henoch-SchoUnlein nephritis and non-Hodgkin's lymphoma. Nephrol Dial Transplant. 2001. 16:1080–1.
32). Blanco P., Denisi R., Rispal P., Deminiere C., Pellegrin JL., Leng B, et al. Henoch-SchoUnlein purpura associated with segmental and focal proliferative glomerulonephritis in a patient with Hodgkin's disease. Nephrol Dial Transplant. 1999. 14:179–80.
33). Arrizabalaga P., Saurina A., Sole M., Blade J. Henoch-SchoUnlein IgA glomerulonephritis complicating myeloma kidneys: case report. Ann Hematol. 2003. 82:526–8.
34). Van Der Helm-Van Mil AH., Smith AC., Pouria S., Tarelli E., Brunskill NJ., Eikenboom HC. Immunoglobulin A multiple myeloma presenting with Henoch-SchoUnlein purpura associated with reduced sialylation of IgA1. Br J Haematol. 2003. 122:915–7.
35). Zickerman AM., Allen AC., Talwar V., Olczak SA., Brownlee A., Holland M, et al. IgA myeloma presenting as Henoch-SchoUnlein purpura with nephritis. Am J Kidney Dis. 2000. 36:E19.
36). Borras-Blasco J., Enriquez R., Amoros F., Cabezuelo JB., Navarro-Ruiz A., Perez M, et al. Henoch-SchoUnlein purpura associated with clarithromycin. Case report and review of literature. Int J Clin Pharmacol Ther. 2003. 41:213–6.
37). Pillebout E., Thervet E., Hill G., Alberti C., Vanhille P., Nochy D. Henoch-SchoUnlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002. 13:1271–8.
38). Piette WW. What is SchoUnlein-Henoch purpura, and why should we care? Arch Dermatol. 1997. 133:515–8.
39). Szer IS. Henoch-SchoUnlein purpura. Curr Opin Rheumatol. 1994. 6:25–31.
40). Shrestha S., Sumingan N., Tan J., Alhous H., McWilliam L., Ballardie F. Henoch SchoUnlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. QJM. 2006. 99:253–65.